Jinhai International Group to Inject 16.5 Million Yuan in Medical Device Seller to Gain 55% Stake

MT Newswires Live07-22

Jinhai International Group Holdings (HKG:2225) unit Jinhai Technology Development (Shanghai) will inject a total of 16.5 million yuan by way of a cash contribution into Shanghai Lichen Medical Technology, a Monday bourse filing said.

Following the capital injection and the increase in Shanghai Lichen Medical Technology's registered capital, Jinhai Technology Development (Shanghai) will own a 55% stake in the former.

The remaining 45% stake will remain held by He Xiao, who is currently the sole shareholder of the medical device and equipment seller.

Jinhai International Group expects to integrate Shanghai Lichen Medical Technology's business activities into its existing business of minimally invasive surgery solution and medical product and related service provision.

Shares of the manpower services provider closed over 1% lower on Monday.

Price (HKD): $4.73, Change: $-0.07, Percent Change: -1.46%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment